Literature DB >> 11528578

Diagnosis of Strongyloides stercoralis infection.

A A Siddiqui1, S L Berk.   

Abstract

Strongyloides stercoralis infects 30 million people in 70 countries. Infection usually results in asymptomatic chronic disease of the gut, which can remain undetected for decades. However, in patients receiving long-term corticosteroid therapy, hyperinfection can occur, resulting in high mortality rates (up to 87%). Strongyloidiasis is difficult to diagnose because the parasite load is low and the larval output is irregular. Results of a single stool examination by use of conventional techniques fail to detect larvae in up to 70% of cases. Several immunodiagnostic assays have been found ineffective in detecting disseminated infections and show extensive cross-reactivity with hookworms, filariae, and schistosomes. Although it is important to detect latent S. stercoralis infections before administering chemotherapy or before the onset of immunosuppression in patients at risk, a specific and sensitive diagnostic test is lacking. This review describes the clinical manifestations of strongyloidiasis, as well as various diagnostic tests and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528578     DOI: 10.1086/322707

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  232 in total

1.  Strongyloides infection in a cardiac transplant recipient: making a case for pretransplantation screening and treatment.

Authors:  Inderpreet S Grover; Rene Davila; Charu Subramony; Sumanth R Daram
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

2.  Strongyloides stercoralis infection in a patient with sickle cell disease.

Authors:  D E Ferastraoaru; N N Jariwala; S P Jariwala
Journal:  Ann Trop Med Parasitol       Date:  2011-12

Review 3.  Strongyloides stercoralis: there but not seen.

Authors:  Martin Montes; Charu Sawhney; Nicolas Barros
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

4.  Prevalence of Strongyloides stercoralis antibodies among a rural Appalachian population--Kentucky, 2013.

Authors:  Elizabeth S Russell; Elizabeth B Gray; Rebekah E Marshall; Stephanie Davis; Amanda Beaudoin; Sukwan Handali; Isabel McAuliffe; Cheryl Davis; Dana Woodhall
Journal:  Am J Trop Med Hyg       Date:  2014-08-25       Impact factor: 2.345

5.  Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis.

Authors:  Chatanun Eamudomkarn; Paiboon Sithithaworn; Jiraporn Sithithaworn; Sasithorn Kaewkes; Banchob Sripa; Makoto Itoh
Journal:  Parasitol Res       Date:  2015-04-17       Impact factor: 2.289

6.  Side Benefits of Mass Drug Administration for Lymphatic Filariasis on Strongyloides stercoralis Prevalence on Pemba Island, Tanzania.

Authors:  Beatrice Barda; Marco Albonico; Dora Buonfrate; Shaali M Ame; Said Ali; Benjamin Speich; Jennifer Keiser
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

7.  A loop-mediated isothermal amplification (LAMP) assay for Strongyloides stercoralis in stool that uses a visual detection method with SYTO-82 fluorescent dye.

Authors:  Matthew R Watts; Gregory James; Yasmin Sultana; Andrew N Ginn; Alexander C Outhred; Fanrong Kong; Jaco J Verweij; Jonathan R Iredell; Sharon C-A Chen; Rogan Lee
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

8.  Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.

Authors:  Tatvam T Choksi; Gul Madison; Tawseef Dar; Mohammed Asif; Kevin Fleming; Leon Clarke; Mervyn Danilewitz; Randa Hennawy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

9.  Flare-up of ulcerative colitis after systemic corticosteroids: a strong case for Strongyloides.

Authors:  Shomron Ben-Horin; Iris Barshack; Yehuda Chowers; Meir Mouallem
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 10.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.